Search Legislation

The Risk Transformation Regulations 2017

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Regulation 190

SCHEDULE 4Consequential amendments to legislation

This schedule has no associated Explanatory Memorandum

PART 1Consequential amendments to primary legislation

Stock Transfer Act 1963

1.  In the Stock Transfer Act 1963(1), in section 1 (simplified transfer of securities), in subsection (4), after paragraph (f), insert—

(g)shares issued by a protected cell company within the meaning of Part 4 of the Risk Transformation Regulations 2017..

Stock Transfer Act (Northern Ireland) 1963

2.  In the Stock Transfer Act (Northern Ireland) 1963(2), in section 1 (simplified transfer of securities), in subsection (4), after paragraph (f), insert—

(g)shares issued by a protected cell company within the meaning of Part 4 of the Risk Transformation Regulations 2017..

Company Directors Disqualification Act 1986

3.  In the Company Directors Disqualification Act 1986(3), after section 22G (application of Act to further education bodies)(4), insert—

Application of Act to protected cell companies

22H.(1) In this section—

(a)“protected cell company” means a protected cell company incorporated under Part 4 of the Risk Transformation Regulations 2017 which has its registered office in England and Wales (or Wales) or Scotland; and

(b)a reference to a part of a protected cell company is a reference to the core or a cell of the protected cell company (see regulations 42 and 43 of the Risk Transformation Regulations 2017).

(2) This Act applies to protected cell companies as it applies to companies.

(3) Accordingly, in this Act, references to a company are to be read as including references to a protected cell company.

(4) As they apply in relation to protected cell companies, the provisions of this Act have effect with the following modifications—

(a)references to the administration, insolvency, liquidation or winding up of a company are to be read as references to the administration, insolvency, liquidation or winding up of a part of a protected cell company;

(b)references to striking off are to be read as including references to dissolution;

(c)references to a director of a company which is or has been insolvent are to be read as references to the director of a protected cell company, a part of which is or has been insolvent;

(d)references to a director of a company which is being or has been wound up are to be read as references to the director of a protected cell company, a part of which is being or has been wound up;

(e)references to the court with jurisdiction to wind up a company are to be read as references to the court with jurisdiction to wind up the parts of a protected cell company;

(f)references to the companies legislation are to be read as references to Part 4 of, and Schedules 1 to 3 to, the Risk Transformation Regulations 2017;

(g)references to the Insolvency Act 1986 are to be read as references to that Act as applied by Part 4 of, and Schedules 1 to 3 to, the Risk Transformation Regulations 2017;

(h)references to section 452 and 456(5) of the Companies Act 2006 are to be read as references to those sections as applied by regulation 163 of the Risk Transformation Regulations 2017;

(i)references to the registrar of companies are to be read as references to the Financial Conduct Authority; and

(j)references to an overseas company include references to a protected cell company incorporated under the Risk Transformation Regulations 2017 which has its registered office in Northern Ireland.

(5) Where two or more parts of a protected cell company are or have been insolvent, then sections 6 to 7A and 8ZA to 8ZC apply in relation to each part separately.

(6) A contribution to the assets of a protected cell company given in accordance with a compensation order under section 15A(1) or a compensation undertaking under section 15A(2) is to be held by the protected cell company on behalf of the part of the protected cell company specified in the order or undertaking..

Companies Act 2006

4.  In the Companies Act 2006—

(a)in section 1040 (companies authorised to register under the Companies Act 2006), in subsection (1), in paragraph (b), after sub-paragraph (iii), insert—

other than a company registered under Part 4 of the Risk Transformation Regulations 2017.;

(b)in section 1043 (unregistered companies), in subsection (1), after paragraph (d), insert—

(e)protected cell companies registered under Part 4 of the Risk Transformation Regulations 2017.;

(c)in section 1099 (the registrar’s index of company names)(6), in subsection (3), after paragraph (e), insert—

(f)protected cell companies registered under Part 4 of the Risk Transformation Regulations 2017..

PART 2Consequential amendments to secondary legislation

The Company Directors Disqualification (Northern Ireland) Order 2002

5.  In the Company Directors Disqualification (Northern Ireland) Order 2002(7), after Article 25B (application of Order to credit unions)(8), insert—

Application of Order to protected cell companies

25C.(1) In this Article—

(a)“protected cell company” means a protected cell company incorporated under Part 4 of the Risk Transformation Regulations 2017 which has its registered office in Northern Ireland; and

(b)a reference to a part of a protected cell company is a reference to the core or a cell of the protected cell company (see regulations 42 and 43 of the Risk Transformation Regulations 2017).

(2) This Order applies to protected cell companies as it applies to companies.

(3) Accordingly, in this Order, references to a company are to be read as including references to a protected cell company.

(4) As they apply in relation to protected cell companies, the provisions of this Order have effect with the following modifications—

(a)references to the administration, insolvency, liquidation or winding up of a company are to be read as references to the administration, insolvency, liquidation or winding up of a part of a protected cell company;

(b)references to striking off are to be read as including references to dissolution;

(c)references to a director of a company which is or has been insolvent are to be read as references to the director of a protected cell company, a part of which is or has been insolvent;

(d)references to a director of a company which is being or has been wound up are to be read as references to the director of a protected cell company, a part of which is being or has been wound up;

(e)references to the companies legislation are to be read as references to Part 4 of, and Schedules 1 to 3 to, the Risk Transformation Regulations 2017;

(f)references to the Insolvency (Northern Ireland) Order 1989 are to be read as references to that Order as applied by Part 4 of, and Schedules 1 to 3 to, the Risk Transformation Regulations 2017;

(g)references to sections 452 and 456 of the Companies Act 2006 are to be read as references to those sections as applied by regulation 163 of the Risk Transformation Regulations 2017;

(h)references to the registrar of companies are to be read as references to the Financial Conduct Authority; and

(i)references to an overseas company include references to a protected cell company incorporated under the Risk Transformation Regulations 2017 which has its registered office in England and Wales (or Wales) or Scotland.

(5) Where two or more parts of a protected cell company are or have been insolvent, then Articles 9 to 10A and 11A to 11C apply in relation to each part separately.

(6) A contribution to the assets of a protected cell company given in accordance with a compensation order under Article 19A(1) or a compensation undertaking under Article 19A(2) is to be held by the protected cell company on behalf of the part of the protected cell company specified in the order or undertaking..

Unregistered Companies Regulations 2009

6.  In the Unregistered Companies Regulations 2009(9), in regulation 2 (interpretation), in sub-paragraph (a)—

(a)at the end of sub-paragraph (iii), delete “or”;

(b)at the end of sub-paragraph (iv), insert “or”;

(c)after sub-paragraph (iv), insert—

(v)a protected cell company registered under Part 4 of the Risk Transformation Regulations 2017.

Company, Limited Liability Partnership and Business (Names and Trading Disclosures) Regulations 2015

7.  In the Company, Limited Liability Partnership and Business (Names and Trading Disclosures) Regulations 2015(10)—

(a)in regulation 16 (“limited” and permitted alternatives), in paragraph (1)—

(i)at the end of sub-paragraph (d), delete “or”;

(ii)at the end of sub-paragraph (e), insert “or”;

(iii)after sub-paragraph (e), insert—

(f)a company registered under Part 4 of the Risk Transformation Regulations 2017 with that name.;

(b)in Schedule 2 (specified words, expressions and abbreviations), in paragraph 3, after sub-paragraph (w), insert—

(wa)“PROTECTED CELL COMPANY” or (with or without full stops) the abbreviations “PCC LIMITED” and “PCC LTD”;

(wb)“CWMNI UNEDAU GWARCHODEDIG” or (with or without full stops) the abbreviations “CUG CYFYNGEDIG” and “CUG CYF”;.

(4)

Section 22G was inserted by section 39 of the Technical and Further Education Act 2017 (c.19).

(5)

Section 456 has been amended by S.I. 2013/1970.

(6)

Section 1099 has been amended by section 151 of and Schedule 4 to the Co-operative and Community Benefit Societies Act 2014 (c.14).

(8)

Article 25B was inserted by section 7 of the Credit Unions and Co-operative and Communities Benefit Socities Act (Northern Ireland) 2016 (2016 c. 16 (N.I.)).

Back to top

Options/Help

Print Options

You have chosen to open The Whole Instrument

The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open The Whole Instrument as a PDF

The Whole Instrument you have selected contains over 200 provisions and might take some time to download.

Would you like to continue?

You have chosen to open the Whole Instrument

The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Impact Assessments

Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:

  • Why the government is proposing to intervene;
  • The main options the government is considering, and which one is preferred;
  • How and to what extent new policies may impact on them; and,
  • The estimated costs and benefits of proposed measures.
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources